Brief: Devyser Establishes Proprietary CLIA Lab, Strengthens Presence On U.S. Market
Nov 9 (Reuters) - Devyser Diagnostics AB DVYSR.ST :
* DEVYSER STRENGTHENS ITS PRESENCE ON THE US MARKET -
ESTABLISHES
PROPRIETARY CLIA LAB
* OBTAINS COMPLETE CONTROL OF SELLING PROCESS, INCLUDING
REIMBURSEMENT MANAGEMENT, ENSURING VALUE-BASED PRICING AND
IMPROVED MARGINS
Source text for Eikon: ID:nWkr5tJrpz
Further company coverage: DVYSR.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Devyser Diagnostics AB
See all newsBrief: Devyser Awarded Tender In Italy Valued At SEK 8.9 Million
Brief: Devyser Diagnostics Appoints Niklas Axelsson As CFO
Sweden's Devyser Q1 net sales rise 12.9%, operating profit turns positive
Brief: Devyser Q1 Sales SEK 61.8 Million
Brief: Devyser Completes Cybergene Acquisition, Carries Out Compensation Share Issue